MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze NTHI →
    • FindStock Picks / Stock Screener
    • Value · NTHIIntrinsic Value Calculator
    • Invest · NTHIInvestment Case
    • Hold · NTHI5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
NTHI stock logo

NTHI

Neonc Technologies Holdings, Inc.

$3.08
0.01
 (0.42%)
Exchange:  NASDAQ
Market Cap:  88.801M
Shares Outstanding:  19.212M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  BiotechnologyView industry performance
   
CEO:  Amir Farrokh Heshmatpour
Full Time Employees:  5
Address: 
23975 Park Sorrento
Calabasas
CA
91302
US
Website:  https://www.neonctech.com
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
NTNTHI logoNTHINeonc Technologies Holdings, Inc.88.8M——229.4%
TNTNXP logoTNXPTonix Pharmaceuticals Holding Corp.88.5M——-74.0%
GNGNLX logoGNLXGenelux Corporation89.1M——-192.2%
PLPLYX logoPLYXPolaryx Therapeutics, Inc. Common Stock91.2M——-47.7%
TNTNYA logoTNYATenaya Therapeutics, Inc.85.9M——-136.8%
ATATRA logoATRAAtara Biotherapeutics, Inc.84.6M——-93.1%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year2025
Revenue39.990
Gross Profit39.990
EBITDA-59,605.182
Operating Income-58,169.198
Net Income-62,146.210

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year2025
Total Assets2,823.634
Total Liabilities20,331.363
Total Stockholders Equity-17,507.729
Total Debt6,313.879
Cash and Cash Equivalents58.729

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year2025
Operating Cash Flow-20,363.948
Capital Expenditure-500
Free Cash Flow-20,863.948
Net Income-62,146.210
Net Change in Cash-6.164

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)117,278.500Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)117,278.500Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)117,278.500Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)49,128.762Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)49,128.762Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)49,128.762Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)12,967.928Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)12,967.928Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)12,967.928Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)125,678,831.372Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)125,678,831.372Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)125,678,831.372Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.680Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.680Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.680Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
0
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
-1.47
?Enterprise Value
 (TTM)
: 
92.26M  ?EV/FCF
 (TTM)
: 
-4.36
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
309.09%  ?ROIC
 (TTM)
: 
229.42%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
-0.02
?P/B
 (TTM)
: 
-4.34  ?Current Ratio
 (TTM)
: 
0.14

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates NTHI intrinsic value between $11.50 – $11.50 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate NTHI Intrinsic Value

Common questions about NTHI valuation

Is Neonc Technologies Holdings, Inc. (NTHI) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Neonc Technologies Holdings, Inc. (NTHI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is NTHI a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether NTHI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is NTHI’s P/E ratio?

You can see NTHI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for NTHI?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is NTHI a good long-term investment?

Whether NTHI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Neonc Technologies Holdings, Inc.

  • Neonc Technologies Holdings, Inc. intrinsic value calculatorEstimate what the business is worth
  • Neonc Technologies Holdings, Inc. 5-year outlookWhat has to go right, and what could go wrong
NTHI

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

0.42
MarketSnap

Trading Metrics:

Open: 3.15   Previous Close: 3.07
Day Low: 3.03   Day High: 3.15
Year Low: 2.5   Year High: 12
Price Avg 50: 3.41   Price Avg 200: 5.41
Volume: 14647   Average Volume: 168457

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

NeOnc's Ambitious Brain Cancer Plans are Setting the Stage
30-10-2026 09:10
NeOnc's Ambitious Brain Cancer Plans are Setting the Stage
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
26-10-2026 09:19
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue
23-10-2026 13:01
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
21-10-2026 10:17
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
21-10-2026 09:35
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
20-10-2026 09:33
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze NTHI →
    • FindStock Picks / Stock Screener
    • Value · NTHIIntrinsic Value Calculator
    • Invest · NTHIInvestment Case
    • Hold · NTHI5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read